Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Stomatitis 2 Neoplasms 2 Thromboembolism 1 Sarcoma 1 Respiratory Insufficiency 1 Prostatic Neoplasms 1 Pneumonia 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Myocardial Infarction 1 Mucositis 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Kidney Diseases 1 Head and Neck Neoplasms 1 Arrhythmias, Cardiac 1 Angina, Unstable 1 Adenocarcinoma 1 Acute Coronary Syndrome 1

Interventions

Docetaxel 158 Prednisone 131 Leuprolide 95 bicalutamide 86 enzalutamide 83 Radiotherapy 80 Goserelin 80 Abiraterone Acetate 76 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 54 Magnetic Resonance Spectroscopy 46 Zoledronic Acid 44 gallium 68 PSMA-11 37 Flutamide 34 abiraterone 32 Estramustine 32 radium Ra 223 dichloride 30 apalutamide 27 Surveys and Questionnaires 26 Gonadotropin-Releasing Hormone 26 Androgen Antagonists 25 cabazitaxel 24 Radiosurgery 24 Dutasteride 22 sipuleucel-T 21 Prednisolone 21 Triptorelin Pamoate 20 Paclitaxel 20 luprolide acetate gel depot 19 Radiation 19 Exercise 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Prostatic Neoplasms × Sodium Bicarbonate × Clear all

NCT06661902 2026-02-17

BURN

University of Washington

Phase 1/2 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡